NEWTOWN, Pa., Oct. 28, 2019 /PRNewswire/ -- CenTrak, Inc., Healthcare's market leader in Enterprise Locating and Sensing Services™ , today announced the launch of its Tru

RICHMOND,Va., Oct. 28, 2019 /PRNewswire/ -- Patient First wants everyone to enjoy the frightful fun this Halloween.  Here are a few reminders to help ensure your "Trick-or-Treaters" have a fun and safe Halloween:

RICHMOND,Va., Oct. 28, 2019 /PRNewswire/ -- Patient First wants everyone to enjoy the frightful fun this Halloween.  Here are a few reminders to help ensure your "Trick-or-Treaters" have a fun and safe Halloween:

ATLANTA, Oct. 28, 2019 /PRNewswire/ -- Quick & Healthy: 50 Simple, Delicious Recipes for Every Day is the newest cookbook from the American Cancer Society. It offers 50 simple, easy-to-prepare recipes that make it easy to cook a variety of healthy dishes for everyone to enjoy at home. 

CAMBRIDGE, United Kingdom, Oct. 28, 2019 /PRNewswire/ -- bit bio (formerly Elpis Biomed) today announced its founding team, a group of pioneering scientists and business executives at the forefront of stem cell biology, cellular reprogramming and cell therapies.  Biotech entrepreneur and scientist Paul Morrill will join as Chief B

MENLO PARK, Calif., Oct. 28, 2019 /PRNewswire/ -- New Enterprise Associates, Inc. (NEA) today announced the promotion of

HOLON, Isreal, Oct. 28, 2019 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its third quarter 2019 financial results on Monday, November 11, 2019 before the U.S. fina

SAN JOSE, Calif., Oct. 28, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against canc

MINNEAPOLIS, Oct. 28, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global leader in the development and manufacturing of Good Manufacturing Practices (GMP)-grade raw and ancillary reagents, announced a commitment to invest between $40 million and $50 million to expand its GMP-grade protein

TRULANCE® (plecanatide) Poster Presentation Recognized with Presidential Poster Award Distinction BRIDGEWATER, N.J., Oct. 28, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the w